Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease
This 2001 randomized controlled trial titled “Ozonized autohemotransfusion improves hemorheological parameters and oxygen delivery to tissues in patients with peripheral occlusive arterial disease” (Annals of Hematology, DOI: [10.1007/s002770100377*) evaluated the impact of ozonized autohemotransfusion in 27 patients with peripheral occlusive arterial disease (POAD) compared to 20 healthy controls. Patients receiving